MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NVCT — Nuvectis Pharma, Inc. Common Stock
NasdaqNuvectis Pharma, Inc. Common Stock
$20.03
-1.36(-6.36%)
- O
- 21.54
- H
- 21.54
- L
- 19.79
- V
- 187.07K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About NVCT
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 4, 2022
Employees13
Stock ExchangeNasdaq
Ticker SymbolNVCT
Websitehttps://www.nuvectis.com
Key Financial Statistics
| Market Cap | $715.56M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.55 - $29.28 |
| 52-Week Avg Volume | 155.8K |
| VWAP | $20.22 |
| Transactions | 4,265 |
| Total Recorded Bars | 1,172 days |